Molecular basis for vulnerability to mitochondrial and oxidative stress in a neuroendocrine CRI-G1 cell line.

Molecular basis for vulnerability to mitochondrial and oxidative stress in a neuroendocrine CRI-G1 cell line.
复制标题

DOI:
10.1371/journal.pone.0014485
复制
发表时间:
2011-01-04
期刊:
影响因子:
3.7
通讯作者:
Margeta M
Margeta M
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Chandiramani N;Wang X;Margeta M

文献摘要

参考文献

被引文献

相似文献

Many age-associated disorders (including diabetes, cancer, and neurodegenerative diseases) are linked to mitochondrial dysfunction, which leads to impaired cellular bioenergetics and increased oxidative stress. However, it is not known what genetic and molecular pathways underlie differential vulnerability to mitochondrial dysfunction observed among different cell types. Starting with an insulinoma cell line as a model for a neuronal/endocrine cell type, we isolated a novel subclonal line (named CRI-G1-RS) that was more susceptible to cell death induced by mitochondrial respiratory chain inhibitors than the parental CRI-G1 line (renamed CRI-G1-RR for clarity). Compared to parental RR cells, RS cells were also more vulnerable to direct oxidative stress, but equally vulnerable to mitochondrial uncoupling and less vulnerable to protein kinase inhibition-induced apoptosis. Thus, differential vulnerability to mitochondrial toxins between these two cell types likely reflects differences in their ability to handle metabolically generated reactive oxygen species rather than differences in ATP production/utilization or in downstream apoptotic machinery. Genome-wide gene expression analysis and follow-up biochemical studies revealed that, in this experimental system, increased vulnerability to mitochondrial and oxidative stress was associated with (1) inhibition of ARE/Nrf2/Keap1 antioxidant pathway; (2) decreased expression of antioxidant and phase I/II conjugation enzymes, most of which are Nrf2 transcriptional targets; (3) increased expression of molecular chaperones, many of which are also considered Nrf2 transcriptional targets; (4) increased expression of β cell-specific genes and transcription factors that specify/maintain β cell fate; and (5) reconstitution of glucose-stimulated insulin secretion. The molecular profile presented here will enable identification of individual genes or gene clusters that shape vulnerability to mitochondrial dysfunction and thus represent potential therapeutic targets for diabetes and neurodegenerative diseases. In addition, the newly identified CRI-G1-RS cell line represents a new experimental model for investigating how endogenous antioxidants affect glucose sensing and insulin release by pancreatic β cells.
DOI: 10.2337/dc06-2011
发表时间: 2007-04-01
期刊: DIABETES CARE
影响因子: 16.2
作者:
Hu, Gang;Jousilahti, Pekka;Tuomilehto, Jaakko
通讯作者: Tuomilehto, Jaakko
DOI: 10.1186/gb-2004-5-10-r80
发表时间: 2004
期刊: Genome biology
影响因子: 12.3
作者:
Gentleman RC;Carey VJ;Bates DM;Bolstad B;Dettling M;Dudoit S;Ellis B;Gautier L;Ge Y;Gentry J;Hornik K;Hothorn T;Huber W;Iacus S;Irizarry R;Leisch F;Li C;Maechler M;Rossini AJ;Sawitzki G;Smith C;Smyth G;Tierney L;Yang JY;Zhang J
通讯作者: Zhang J
DOI: 10.1126/science.1077209
发表时间: 2003-01-10
期刊: SCIENCE
影响因子: 56.9
作者:
Bonifati, V;Rizzu, P;Heutink, P
通讯作者: Heutink, P
DOI: 10.1016/j.parkreldis.2009.02.013
发表时间: 2009-11-01
影响因子: 4.1
作者:
D'Amelio, Marco;Ragonese, Paolo;Savettieri, Giovanni
通讯作者: Savettieri, Giovanni
DOI: 10.1073/pnas.0607260103
发表时间: 2006-10-10
影响因子: 11.1
作者:
Clements, Casey M.;McNally, Richard S.;Ting, Jenny P-Y.
通讯作者: Ting, Jenny P-Y.